Published in Blood Weekly, February 17th, 2005
In a recent study, anesthesiologists in the United States "examined a novel method to detect platelet inhibition" using TEG.
"We hypothesized that this method would be suitable for monitoring the antiplatelet effects of eptifibatide (Integrilin)," explained N. Katori and coauthors at the Emory University Hospital. "Whole blood from healthy volunteers was anticoagulated with 3.2% citrate or unfractionated heparin (7 IU/mL)."
"For the platelet aggregation test, both citrate and heparinized samples were spiked with increasing concentrations of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.